353 related articles for article (PubMed ID: 33222771)
21. Overcoming barriers in Pseudomonas aeruginosa lung infections: Engineered nanoparticles for local delivery of a cationic antimicrobial peptide.
d'Angelo I; Casciaro B; Miro A; Quaglia F; Mangoni ML; Ungaro F
Colloids Surf B Biointerfaces; 2015 Nov; 135():717-725. PubMed ID: 26340361
[TBL] [Abstract][Full Text] [Related]
22. Nanometric ion pair complexes of tobramycin forming microparticles for the treatment of Pseudomonas aeruginosa infections in cystic fibrosis.
Sardo C; Di Domenico EG; Porsio B; De Rocco D; Santucci R; Ascenzioni F; Giammona G; Cavallaro G
Int J Pharm; 2019 May; 563():347-357. PubMed ID: 30935918
[TBL] [Abstract][Full Text] [Related]
23. Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections.
Yu S; Wang S; Zou P; Chai G; Lin YW; Velkov T; Li J; Pan W; Zhou QT
Int J Pharm; 2020 Feb; 575():118915. PubMed ID: 31816354
[TBL] [Abstract][Full Text] [Related]
24. Inhalation treatment of idiopathic pulmonary fibrosis with curcumin large porous microparticles.
Hu Y; Li M; Zhang M; Jin Y
Int J Pharm; 2018 Nov; 551(1-2):212-222. PubMed ID: 30227240
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation.
Vakilinezhad MA; Amini A; Dara T; Alipour S
Colloids Surf B Biointerfaces; 2019 Dec; 184():110515. PubMed ID: 31585308
[TBL] [Abstract][Full Text] [Related]
26. Oxyresveratrol Inhibits R848-Induced Pro-Inflammatory Mediators Release by Human Dendritic Cells Even When Embedded in PLGA Nanoparticles.
Gaglio SC; Donini M; Denbaes PE; Dusi S; Perduca M
Molecules; 2021 Apr; 26(8):. PubMed ID: 33916909
[TBL] [Abstract][Full Text] [Related]
27. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
[TBL] [Abstract][Full Text] [Related]
28. Controlled release pulmonary administration of curcumin using swellable biocompatible microparticles.
El-Sherbiny IM; Smyth HD
Mol Pharm; 2012 Feb; 9(2):269-80. PubMed ID: 22136259
[TBL] [Abstract][Full Text] [Related]
29. Ciprofloxacin-loaded PLGA nanoparticles against cystic fibrosis P. aeruginosa lung infections.
Günday Türeli N; Torge A; Juntke J; Schwarz BC; Schneider-Daum N; Türeli AE; Lehr CM; Schneider M
Eur J Pharm Biopharm; 2017 Aug; 117():363-371. PubMed ID: 28476373
[TBL] [Abstract][Full Text] [Related]
30. Microfluidic Assisted Nanoprecipitation of PLGA Nanoparticles for Curcumin Delivery to Leukemia Jurkat Cells.
Leung MHM; Shen AQ
Langmuir; 2018 Apr; 34(13):3961-3970. PubMed ID: 29544247
[TBL] [Abstract][Full Text] [Related]
31. Overcoming dose limitations using the orbital(®) multi-breath dry powder inhaler.
Young PM; Crapper J; Philips G; Sharma K; Chan HK; Traini D
J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):138-47. PubMed ID: 24004178
[TBL] [Abstract][Full Text] [Related]
32. Novel combination proliposomes containing tobramycin and clarithromycin effective against Pseudomonas aeruginosa biofilms.
Ye T; Sun S; Sugianto TD; Tang P; Parumasivam T; Chang YK; Astudillo A; Wang S; Chan HK
Int J Pharm; 2018 Dec; 552(1-2):130-138. PubMed ID: 30267753
[TBL] [Abstract][Full Text] [Related]
33. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
Li X; Vogt FG; Hayes D; Mansour HM
Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
[TBL] [Abstract][Full Text] [Related]
34. Enhanced Antitumor Efficacy of Curcumin-Loaded PLGA Nanoparticles Coated with Unique Fungal Hydrophobin.
Sun L; Xu H; Xu JH; Wang SN; Wang JW; Zhang HF; Jia WR; Li LS
AAPS PharmSciTech; 2020 Jun; 21(5):171. PubMed ID: 32529560
[TBL] [Abstract][Full Text] [Related]
35. Spray dried curcumin loaded nanoparticles for antimicrobial photodynamic therapy.
Preis E; Baghdan E; Agel MR; Anders T; Pourasghar M; Schneider M; Bakowsky U
Eur J Pharm Biopharm; 2019 Sep; 142():531-539. PubMed ID: 31362056
[TBL] [Abstract][Full Text] [Related]
36. Ciprofloxacin-loaded polymeric nanoparticles incorporated electrospun fibers for drug delivery in tissue engineering applications.
Günday C; Anand S; Gencer HB; Munafò S; Moroni L; Fusco A; Donnarumma G; Ricci C; Hatir PC; Türeli NG; Türeli AE; Mota C; Danti S
Drug Deliv Transl Res; 2020 Jun; 10(3):706-720. PubMed ID: 32100267
[TBL] [Abstract][Full Text] [Related]
37. Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infections.
Lin Y; Chang RYK; Britton WJ; Morales S; Kutter E; Li J; Chan HK
Eur J Pharm Biopharm; 2019 Sep; 142():543-552. PubMed ID: 31398437
[TBL] [Abstract][Full Text] [Related]
38. Nano into Micro Formulations of Tobramycin for the Treatment of Pseudomonas aeruginosa Infections in Cystic Fibrosis.
Porsio B; Cusimano MG; Schillaci D; Craparo EF; Giammona G; Cavallaro G
Biomacromolecules; 2017 Dec; 18(12):3924-3935. PubMed ID: 29111673
[TBL] [Abstract][Full Text] [Related]
39. Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection.
Abdelghany SM; Quinn DJ; Ingram RJ; Gilmore BF; Donnelly RF; Taggart CC; Scott CJ
Int J Nanomedicine; 2012; 7():4053-63. PubMed ID: 22915848
[TBL] [Abstract][Full Text] [Related]
40. Diclofenac sodium loaded PLGA nanoparticles for inflammatory diseases with high anti-inflammatory properties at low dose: Formulation, characterization and in vivo HET-CAM analysis.
Öztürk AA; Namlı İ; Güleç K; Kıyan HT
Microvasc Res; 2020 Jul; 130():103991. PubMed ID: 32105668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
